A carregar...
EZH2 inhibitor GSK343 inhibits sepsis-induced intestinal disorders
Enhancer of zeste homolog 2 (EZH2) is positively associated with poor clinical outcomes in a number of aggressive tumors. Recent studies have demonstrated that inhibition of EZH2 also suppressed the inflammatory response during sepsis. The present study aimed to investigate whether an inhibitor of E...
Na minha lista:
| Publicado no: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7967880/ https://ncbi.nlm.nih.gov/pubmed/33747174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.9854 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|